SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending after breaking to new all-time highs fueled by strong institutional demand and positive sentiment surrounding its data center CPU growth and potential hardware partnerships with frontier AI labs. The community remains deeply divided, with bulls pointing to the company's expanding role in AI compute and agentic workflows, while vocal bears argue the rapid momentum is detached from fundamentals and represents an overextended bubble.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing significant volatility as investors react to a Q1 earnings beat that was overshadowed by a disappointing Q2 guidance miss and the departure of co-founder Reed Hastings from the board. The community is sharply divided, with many debating whether the drop presents a prime buying opportunity for a long-term profit machine or if structural concerns and leadership changes signal an end to its aggressive growth era.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing significant volatility and surging volume as investors react to reports of a pending executive order that would prioritize federal research into the therapeutic use of ibogaine for PTSD. The community is heavily focused on the stock's extremely low float and its potential to spark a massive short squeeze, with active debates continuing over the legitimacy of the catalyst versus concerns regarding the company's history of reverse splits and dilution.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently locked in a tug-of-war at the 75k resistance level, with sentiment split between retail traders bracing for a potential breakout and skeptics questioning its correlation to traditional markets. Community discussions are heavily focused on the impact of upcoming legislative acts, institutional buying pressure from ETFs, and the ongoing debate surrounding geopolitical developments as potential catalysts for the next major move.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a surge in investor interest driven by a strategic pivot into AI foundry services, fueled by partnerships with major hyperscalers like Google and potential infrastructure collaborations involving the broader Tesla ecosystem. While the community is actively debating the stock's recent rapid valuation expansion, sentiment remains divided between those betting on long-term foundry turnaround potential and others cautioning against momentum-driven overvaluation ahead of upcoming earnings.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors closely watch for upcoming fiscal year guidance and backlog updates, with the community actively debating the company's valuation as a foundational software provider for software-defined vehicles. Sentiment remains divided between long-term believers who are focused on the expansion of QNX into robotics and defense, and those expressing frustration over past stock performance and management execution.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

BUTTCOIN is trending as the community rallies around its status as the original 2011 internet satire, positioning it as an authentic, long-standing historical asset rather than just another fleeting meme. Investors are actively debating its longevity and potential for a multi-billion-dollar valuation, with many pointing to locked supply and historical roots as key drivers for their conviction.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor heightened geopolitical focus on Greenland's strategic rare earth deposits and the potential for domestic supply chain mandates. The community is actively debating the project's long-term economic potential while speculating on the impact of upcoming pilot plant results and broader U.S.-led critical mineral trade policies.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels Inc. is attracting significant attention as investors react to a combination of strong institutional support and a pivotal leadership transition, with Ross Bhappu set to take the helm. The community is focused on the company's dual role as a critical minerals and uranium provider, tracking technical patterns like the cup-and-handle formation while monitoring how ongoing geopolitical tensions and the push for domestic supply chains will influence future production and market valuation.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing significant attention as it consolidates near key resistance levels, with the community actively debating whether it is positioned for a breakout or further volatility. Sentiment is being heavily influenced by anticipation of the upcoming CLARITY Act and institutional accumulation, leading traders to closely watch for a definitive move that could signal a broader altcoin market shift.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships

Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient...

Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion

Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under...

AI, Biotech, and Defense Converge: Small Caps Chase Big Markets as Innovation Narrative Heats Up

Today's top stocks include $LNAI, $HCTI, $TGNT, $KOD, $NAVN, $BTBD

Lunai Bioworks Unveils AI-Driven National Consortium to Fast-Track Chemical Defense Countermeasures

Lunai Bioworks (NASDAQ:LNAI) launched a new national consortium aimed at transforming how the United States develops medical countermeasures against emerging chemical threats. Operating through its subsidiary BioSymetrics, the company introduced the Pathfinder Consortium, an academic-industry alliance designed to unify historically fragmented chemical defense efforts across government, academia, and biotech into a single, execution-focused platform.

<ul class="summary-bullets"><li>The deal would expand Lunai’s capacity to develop treatments for neurological disorders.</li><li>The transaction is executed through Series B Convertible Preferred shares at a fixed conversion price of $1.5 per share.</li><li>The acquired technology enables compounds to remain inactive in the body until they reach the brain, where they are selectively activated.</li></ul>Lunai Bioworks, Inc. (LNAI) announced a $20 million acquisition to advance its central nervous system (CNS) drug development.&nbsp;The company will acquire blood-brain barrier (BBB) delivery technology and Alzheimer's therapeutic assets for $20 million from the Clemann Group, SAS, or its assignee, marking an expansion of Lunai’s capabilities in neurological drug research.<h2 class="st-heading-2">Transforming CNS Drug Delivery</h2>The transaction is structured as Series B Convertible Preferred shares at a fixed conversion price of $1.5 per share, with a cap on beneficial ownership at 19.9% to remain compliant with Nasdaq regulations.&nbsp;The newly acquired delivery platform addresses one of the most persistent challenges in central nervous system (CNS) drug development, which is the effective transport of therapeutics across the blood-brain barrier.The technology ensures that compounds remain inactive in the body until reaching the brain, where they activate to target specific neurological pathways.&nbsp;<a href="https://stocktwits.com/symbol/LNAI">Lunai Bioworks stock</a> traded over 25% higher on Thursday morning. On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory amid ‘high’ message volume levels.&nbsp;<h2 class="st-heading-2">Strengthening Lunai’s Alzheimer’s Pipeline</h2>This acquisition directly strengthens Lunai’s Alzheimer’s program by combining validated target identification with a strong delivery method. The platform enables advanced treatments for CNS disorders where conventional drugs face penetration limitations, potentially improving both safety and effectiveness.&nbsp;<blockquote>&nbsp;"We are now combining the ability to identify the right biology with a validated mechanism to deliver therapies directly into the brain.”— David Weinstein, CEO, Lunai Bioworks</blockquote>On March 19, Lunai launched the Pathfinder Consortium, a national academic-industry alliance to accelerate the development of chemical countermeasures for battlefield and terrorism threats.&nbsp;LNAI stock has declined by over 35% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-aiff-stock-surge-pre-market-today/cZ3rwPpRIjD">Why Did AIFF Stock Surge Over 20% Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Lunai Bioworks logo is seen displayed on a smartphone screen

Why Did LNAI Stock Surge Over 25% Today? 

Lunai is acquiring $20 million in blood-brain barrier delivery tech and Alzheimer’s assets from Clemann Group.

Equity

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS...

Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model Lunai Bioworks (NASDAQ: LNAI...

Best Manufacturing Stocks To Watch Today - March 17th

Taiwan Semiconductor Manufacturing, Applied Materials, and Lunai Bioworks are the three Manufacturing stocks to watch today, according to MarketBeat's stock screener tool. Manufacturing stocks are...

<ul class="summary-bullets"><li>In January, Lunai announced a new product named Sentinel, an AI safeguard that is designed to be embedded directly within large language and scientific foundation models to prevent the generation of novel chemical agents.</li><li>The company said in February that its newly issued patent covers a key first step in its platform that standardizes data and removes bias before AI modeling begins.</li><li>Lunai announced in March that it had furloughed some employees in the U.S. and Canada on February 27, noting that this was a temporary measure.</li></ul>Lunai Bioworks Inc. (LNAI) shares soared more than 200% in Tuesday’s opening trade before shedding some of the gains to hover about 150% higher to chalk a one-month high.While Lunai has&nbsp;not made&nbsp;any&nbsp;announcements recently nor has it made a fresh filing with the U.S. Securities and Exchange Commission (SEC), the stock could be drawing retail interest amid an increased interest in AI on the sidelines of Nvidia’s GTC event.Lunai announced in February that it has locked down its core AI architecture with the issuance of a fresh patent to enable precision disease subtyping.Despite the LNAI stock soaring on Tuesday, the company’s shares are still down more than 93% from the stock’s 52-week high of $7.7.<h2 class="st-heading-2">What Is The Patent About?</h2>Lunai said its patent covers a key first step in its platform that standardizes data and removes bias before AI modeling begins.Since AI drug discovery depends on data quality, the system is designed to detect and fix inconsistencies across genomic, clinical, imaging, and other datasets to improve reliability, the company said.By strengthening this core data layer, Lunai stated that it aims to better identify patient subtypes and link them to the gene networks driving specific diseases.“This patent protects the critical first step in our closed-loop AI architecture, increasing confidence in biomarker discovery, disease stratification, and gene network mapping across our CNS and biodefense programs,” said Lunai CEO David Weinstein.<h2 class="st-heading-2">Lunai Announces Sentinel</h2>In January, Lunai announced a new product named Sentinel, an AI safeguard that is designed to be embedded directly within large language and scientific foundation models to prevent the generation of novel chemical agents.The company said that Sentinel is a real-time biosecurity layer that screens molecular outputs before they are produced, stopping potentially hazardous designs at the source.<h2 class="st-heading-2">Lunai Announces Furloughs</h2>Lunai announced in March that it had furloughed some employees in the U.S. and Canada on February 27, noting that this was a temporary measure.The company also said that its CEO and CFO have agreed to temporarily defer the payment of their salaries during this period. It noted that this measure will be in place until it is able to secure additional capital.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/LNAI">Lunai Bioworks</a> trended in the ‘extremely bullish’ territory with message volumes at ‘extremely high’ levels at the time of writing.Meanwhile, Koyfin data shows that the short interest in Lunai Bioworks is at 3.3%, up from 1.5% last week.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260317_101902624_png_c94660d562.webp" alt="LNAI stock short interest as on March 17, 2026" width="2400" height="1240"><figcaption>LNAI stock short interest as on March 17, 2026 | Koyfin</figcaption></figure>The company announced in February that it had received a delisting notice from the Nasdaq, while adding that the exchange had granted a request for a hearing, which has been scheduled for March 26, 2026. As a result, the delisting action has been stayed pending a final decision by the exchange.<a href="https://stocktwits.com/symbol/LNAI">LNAI stock</a> is down 42% year-to-date and 93% over the past 12 months. The Vanguard Total Stock Market Index Fund ETF Shares (VTI) and the Vanguard Extended Market Index Fund ETF Shares (VXF) are up 18% in this period.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/uber-nvidia-partnership-quells-wall-street-concerns-for-ride-hailing-giant/cZ3EJfXRIX0">Uber's Nvidia Partnership For Autonomous Vehicles Quells Wall Street's Concerns For Ride-Hailing Giant</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is This Micro-Cap Biotech Stock Up 150% Today?

Despite the LNAI stock soaring on Tuesday, the company’s shares are still down more than 93% from the stock’s 52-week high of $7.7.

Why Is LNAI Stock Skyrocketing Today?

Top Biotech Stocks To Follow Today - March 17th

Vertex Pharmaceuticals, bioAffinity Technologies, Lunai Bioworks, Danaher, Moderna, ImmunityBio, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Current Price	$0.304
Prev Close	$0.3229
Open	$0.3047
Dividend Yield	0.00%
50-Day Moving Average	$0.4467
Beta	1.41
Avg. Volume	44.25M
PE Ratio	-0.04

52-Week High	$5.50
52-Week Low	$0.1513
Market Capitalization	$11.71M
EPS (Annual)	-$10.78
Price to Book	-0.54
Revenue Per Employee	$0.00

LNAI
Lunai Bioworks Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LNAI News

LNAILunai Bioworks Inc.